Appendicitis incidence is highest in young people aged 10–30 years, a relatively healthy age group that does not get much ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

At least 58 cases have been confirmed. Health officials — who are scrambling to get a handle on the vaccine-preventable ...

GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...

A month-long catch-up vaccination campaign has been launched in Rawalpindi district to immunise children aged 2 to 5 years ...

As the first university semester of 2025 gets underway across the country, students and parents are being urged to educate ...

Scientists in Spain detected Enterovirus C105 (EV-C105), a rare virus linked to respiratory and possible neurological illness ...

Meningococcal Vaccine MarketThe global meningococcal vaccine market is experiencing significant growth, driven by rising ...

By Rafiq Nungor ADAMThe Health Minister, Kwabena Mintah Akandoh, has vowed to tackle the meningitis situation in Upper West ...

US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake ...

A programme that tracks and monitors infectious diseases across the country has seen a steady rise in certain disease cases ...

Experts warn of undetected neurologic complications in young children as flu activity increases in the US. Learn more about the research findings.